Tetra Bio-Pharma Inc.
TBP
शेयरों में रैंक
#35354
Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical... Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical company focused on discovering and developing cannabinoid-based medications. Their efforts span several therapeutic areas, including inflammation, pain management, ophthalmology, and oncology. The company's pipeline features various drug candidates: PLENITUDE is being developed for cancer-related pain in advanced patients, while REBORN addresses breakthrough cancer pain. Reduvo is designed to combat chemotherapy-induced nausea and vomiting. ARDS-003 targets sepsis and the prevention of acute respiratory distress syndrome, and SERENITY aims to treat cancer cachexia. Furthermore, Tetra Bio-Pharma is advancing PPP003 for painful dry eye and uveitis pain, and HCC011 for hepatocellular carcinoma.
शेयर मूल्य
$0.01851783
अंतिम समन्वयन: 2023-05-23
मार्केट कैप
$3.71M
बदलाव (1 दिन)
-0.04%
बदलाव (1 वर्ष)
1,443.15%
देश
CA
व्यापार Tetra Bio-Pharma Inc. (TBP)
श्रेणी
Healthcare
Tetra Bio-Pharma Inc. (TBP) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $0.00 (2023-10-01 को)
दिन का सबसे निम्न समापन मूल्य: $0.28 (2011-07-01 को)
दिन का सबसे निम्न समापन मूल्य: $0.28 (2011-07-01 को)
Tetra Bio-Pharma Inc. के स्टॉक मूल्य का इतिहास 2011 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
| वर्ष | प्रदर्शन |
|---|---|
| 2023 | -95.84% |
| 2022 | -82.62% |
| 2021 | -21.66% |
| 2020 | -60.26% |
| 2019 | -40.62% |
| 2018 | -5.58% |
| 2017 | 216.26% |
| 2016 | 899.04% |
| 2015 | -56.08% |
| 2014 | 17.07% |
| 2013 | 0.00% |
| 2012 | -69.35% |
| 2011 | 0.00% |
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
| कंपनी | स्टॉक मूल्य | परिवर्तन 1व% | देश |
|---|---|---|---|
| $525.12 | 23.14% |
US
|
|
| $237.61 | 784.95% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $887.75 | 9.04% |
NL
|
|
| $289.96 | 1.88% |
BE
|
